Protein detail

ADA33

Disintegrin and metalloproteinase domain-containing protein 33 (ADAM 33) (EC 3.4.24.-)

Entry name
ADA33
UniProt ID
EVMP confidence score
0.40
Supporting publications (n)
1
Transmembrane count
1
Protein classification
Disease related genesHuman disease related genesPredicted membrane proteins
Basic Information
Protein Names
Disintegrin and metalloproteinase domain-containing protein 33 (ADAM 33) (EC 3.4.24.-)
Protein Class (3)
Disease related genesHuman disease related genesPredicted membrane proteins
Protein Function (2)
  • Human disease related genes:Immune system diseases:Allergies and autoimmune diseases
  • Disease related genes
Transmembrane
702..722; Helical
Transmembrane Count
1
Entrez Gene Symbol
Gene Synonym (3)
C20orf153dJ964F7.1DKFZp434K0521
Gene Description
ADAM metallopeptidase domain 33
Chromosome
20
Position
3667965-3682246
Supporting publications (n)
1
EVMP confidence score
0.40
Fluorescence & Localization
Tissue SpecificliverCell SpecificCholangiocytes
Function & Pathway
Relations & Evidence24

Ligand-Receptor Signaling (23)

23 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
receptorreceptorOmniPathYesYes
intracellularintracellularComPPIYes
intracellularintracellularOmniPathYes
ecm_regulatorecm_regulatorMatrisomeYesYes
ecm_regulatorecm_regulatorOmniPathYesYes
cell_surface_enzymecell_surface_enzymeSurfaceomeYesYes
cell_surface_enzymecell_surface_enzymeOmniPathYesYes
transmembranetransmembraneUniProt_locationYes
transmembranetransmembraneUniProt_topologyYes
transmembranetransmembraneUniProt_keywordYes
Page 1 of 3Next

Isolation & Detection Technology (1)

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
Differential UltracentrifugationSize Exclusion ChromatographyMass spectrometryR Sequencing22575517936982312
Sequence, Structure & Domains

Sequences

Length
813
Mass
87,739
Sequence
MGWRPRRARGTPLLLLLLLLLLWPVPGAGVLQGHIPGQPVTPHWVLDGQPWRTVSLEEPVSKPDMGLVALEAEGQELLLELEKNHRLLAPGYIETHYGPDGQPVVLAPNHTDHCHYQGRVRGFPDSWVVLCTCSGMSGLITLSRNASYYLRPWPPRGSKDFSTHEIFRMEQLLTWKGTCGHRDPGNKAGMTSLPGGPQSRGRREARRTRKYLELYIVADHTLFLTRHRNLNHTKQRLLEVANYVDQLLRTLDIQVALTGLEVWTERDRSRVTQDANATLWAFLQWRRGLWAQRPHDSAQLLTGRAFQGATVGLAPVEGMCRAESSGGVSTDHSELPIGAAATMAHEIGHSLGLSHDPDGCCVEAAAESGGCVMAAATGHPFPRVFSACSRRQLRAFFRKGGGACLSNAPDPGLPVPPALCGNGFVEAGEECDCGPGQECRDLCCFAHNCSLRPGAQCAHGDCCVRCLLKPAGALCRQAMGDCDLPEFCTGTSSHCPPDVYLLDGSPCARGSGYCWDGACPTLEQQCQQLWGPGSHPAPEACFQVVNSAGDAHGNCGQDSEGHFLPCAGRDALCGKLQCQGGKPSLLAPHMVPVDSTVHLDGQEVTCRGALALPSAQLDLLGLGLVEPGTQCGPRMVCQSRRCRKNAFQELQRCLTACHSHGVCNSNHNCHCAPGWAPPFCDKPGFGGSMDSGPVQAENHDTFLLAMLLSVLLPLLPGAGLAWCCYRLPGAHLQRCSWGCRRDPACSGPKDGPHRDHPLGGVHPMELGPTATGQPWPLDPENSHEPSSHPEKPLPAVSPDPQADQVQMPRSCLW
Alternative Products
Event=Alternative splicing; Named isoforms=3; Name=1; IsoId=Q9BZ11-1; Sequence=Displayed; Name=2; IsoId=Q9BZ11-2; Sequence=VSP_005495; Name=3; IsoId=Q9BZ11-3; Sequence=VSP_015421, VSP_005495
Alternative Sequence
1..478; Missing (in isoform 3); 636..661; Missing (in isoform 2 and isoform 3)

3D Structural Models

Turn
226..228; 322..324; 399..402
Helix
220..225; 230..248; 249..251; 275..292; 307..309; 336..350; 366..368; 387..398; 403..406
Beta Strand
210..218; 253..262; 264..266; 296..303; 326..330; 333..335
3D Structure
X-ray crystallography (2)

Domain & Motif Annotations

Compositional Bias
780..791; Basic and acidic residues
Motif
131..138; Cysteine switch
Domain (CC)
The conserved cysteine present in the cysteine-switch motif binds the catalytic zinc ion, thus inhibiting the enzyme. The dissociation of the cysteine from the zinc ion upon the activation-peptide release activates the enzyme.
Domain (FT)
210..409; Peptidase M12B; 417..503; Disintegrin; 649..681; EGF-like
Region
184..205; Disordered; 746..813; Disordered
Clinical Relevance
Disease Involvement
Asthma
Related Diseases
Antibody (2)
Supporting Publications1
PMIDTitleRelated sentences
32795414Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers.Among traditional exosome markers, CD9, HSPA8, ALIX, and HSP90AB1 represent pan-EVP markers, while ACTB, MSN, and RAP1B are novel pan-EVP markers.